BILLERICA, Mass., April 27, 2017 /PRNewswire/ -- Entegris, Inc. (NasdaqGS: ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, today reported its financial results for the Company's first quarter ended April 1, 2017.

First-quarter sales were $317.4 million, an increase of 18.9% from the same quarter last year and a 2.9% increase sequentially. First-quarter net income was $32.5 million, or $0.23 per diluted share, which included amortization of intangible assets of $10.9 million. Non-GAAP net income was $40.8 million, or $0.28 per diluted share.

Bertrand Loy, president and chief executive officer, said: "I am very pleased to report another extremely successful quarter, which reflects the growing importance of our value proposition and the quality of execution by our teams around the world. First-quarter sales reached an all-time high driven by strength across all businesses and record demand for microfiltration and advanced deposition products. In large part, the introduction of new materials is making possible the next level of semiconductor device performance, and we believe that our expertise in advanced materials combined with our broad array of purification and fluid handling solutions will be key enablers of our industry's innovations."

Mr. Loy added: "We generated record quarterly adjusted EBITDA of $75.8 million, or 23.9% of revenue. In addition to pursuing organic growth prospects for the company, we continued to execute our capital allocation strategy by paying down $25 million of debt in the first quarter and by completing the acquisition of a complementary and accretive liquid filtration product line from W. L. Gore & Associates, Inc."

Quarterly Financial Results Summary
(in thousands, except per share data)



    GAAP Results                   Q1-2017       Q1-2016       Q4-2016
    ------------                   -------       -------       -------

    Net sales                         $317,377       $267,024       $308,502
    ---------                         --------       --------       --------

    Operating income                   $50,920        $29,559        $44,905
    ----------------                   -------        -------        -------

    Operating margin                     16.0%         11.1%         14.6%

    ---                                                                ---

    Net income                         $32,514        $16,212        $26,098
    ----------                         -------        -------        -------

    Diluted earnings per share
     (EPS)                               $0.23          $0.11          $0.18
    --------------------------           -----          -----          -----

    Non-GAAP Results

    Non-GAAP adjusted
     operating income                  $61,865        $40,848        $55,843
    -----------------                  -------        -------        -------

    Adjusted operating margin           19.5 %         15.3%         18.1%
    -------------------------            -----           ----           ----

    Non-GAAP net income                $40,754        $23,617        $34,294
    -------------------                -------        -------        -------

    Non-GAAP EPS                         $0.28          $0.17          $0.24
    ------------                         -----          -----          -----

Second-Quarter Outlook

For the second quarter ending July 1, 2017, the Company expects sales of $315 million to $330 million, net income of $32 million to $37 million, and net income per diluted share between $0.22 and $0.26. On a non-GAAP basis, EPS is expected to range from $0.27 to $0.31 per diluted share, which reflects net income on a non-GAAP basis in the range of $39 million to $44 million, which is adjusted for expected amortization expense of approximately $11 million or $0.05 per share.

Segment Results

As of December 31, 2016, the Company changed its financial segment reporting to the following segments:

Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases, and materials and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.

Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.

Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.

First-Quarter Results Conference Call Details

Entegris will hold a conference call to discuss its results for the first quarter on Thursday, April 27, 2017, at 9:30 a.m. Eastern Time. Participants should dial 1-888-778-9067 or 1-913-981-5587, referencing confirmation code 5731098. Participants are asked to dial in 5 to 10 minutes prior to the start of the call. To access a telephonic replay of the call, please Click Here. The replay will be available starting at 12:30 p.m. ET on Thursday, April 27 until Saturday, June 10. A live and on-demand webcast of the call can also be accessed from the investor relations section of Entegris' website at www.entegris.com.

Management's slide presentation concerning the results for the first quarter, which may be referred to during the call, will be posted on the investor relations section of www.entegris.com Thursday morning before the call.

ABOUT ENTEGRIS

Entegris is a leader in specialty chemicals and advanced materials solutions for the microelectronics industry and other high-tech industries. Entegris is ISO 9001 certified and has manufacturing, customer service and/or research facilities in the United States, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea and Taiwan. Additional information can be found at www.entegris.com.

Non-GAAP Information

The Company's condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (GAAP). Adjusted EBITDA, Adjusted Gross Profit, Adjusted Segment Profit, and Adjusted Operating Income together with related measures thereof, and non-GAAP EPS, are considered "Non-GAAP financial measures" under the rules and regulations of the Securities and Exchange Commission. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company uses these non-GAAP financial measures for financial and operational decision-making, as a means to evaluate period-to-period comparisons, as well as comparisons to our competitors' operating results. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance and liquidity by excluding certain items that may not be indicative of our recurring business operating results, such as amortization, depreciation and discrete cash charges that are infrequent in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing and understanding our results and performance and when planning, forecasting, and analyzing future periods. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze our business. The reconciliations of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA, GAAP Gross Profit to Adjusted Gross Profit, GAAP Segment Profit to Adjusted Operating Income, and GAAP to Non-GAAP Earnings per Share are included elsewhere in this release.

Forward-Looking Statements

Certain information contained in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current management expectations only as of the date of this press release, and involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Statements that include such words as "anticipate," "believe," "estimate," "expect," "forecast," "may," "will," "should" or the negative thereof and similar expressions as they relate to Entegris or our management are intended to identify such forward-looking statements. These statements, including those relating to market trends and financial projections, are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These risks include, but are not limited to, fluctuations in the market price of Entegris' stock, Entegris' future operating results, other acquisition and investment opportunities available to Entegris, general business and market conditions and other factors. Additional information concerning these and other risk factors may be found in previous financial press releases issued by Entegris and Entegris' periodic public filings with the Securities and Exchange Commission, including discussions appearing under the headings "Risks Relating to our Business and Industry," "Risks Relating to Our Indebtedness," "Manufacturing Risks," "International Risks," and "Risks Related to Owning Our Common Stock" in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, filed with the U.S Securities and Exchange Commission on February 17, 2017, as well as other matters and important factors disclosed previously and from time to time in the filings of Entegris with the U.S. Securities and Exchange Commission. Except as required under the federal securities laws and the rules and regulations of the Securities and Exchange Commission, we undertake no obligation to update publicly any forward-looking statements contained herein.



                    Entegris, Inc. and Subsidiaries
            Condensed Consolidated Statements of Operations
                 (In thousands, except per share data)
                              (Unaudited)


                                                         Three months ended

                                                April 1,     April 2,     December 31,
                                                  2017          2016            2016
                                            ---------     ---------     ------------

    Net sales                                 $317,377      $267,024         $308,502

    Cost of sales                              177,781       152,318          176,702

                 Gross profit                    139,596       114,706          131,800

    Selling, general and
     administrative
     expenses                                   50,492        47,956           48,734

    Engineering, research
     and development
     expenses                                   27,239        25,902           27,223

    Amortization of
     intangible assets                          10,945        11,289           10,938

                 Operating income                 50,920        29,559           44,905

    Interest expense, net                        8,393         9,149            8,983

    Other expense
     (income), net                                 902         (675)           1,303
                                                   ---          ----            -----

                  Income before income tax
                  expense                         41,625        21,085           34,619

    Income tax expense                           9,111         4,873            8,521

                 Net income                      $32,514       $16,212          $26,098
                                               =======       =======          =======



    Basic net income per
     common share:                               $0.23         $0.12            $0.18

    Diluted net income
     per common share:                           $0.23         $0.11            $0.18


    Weighted average shares
     outstanding:

                 Basic                           141,501       140,780          141,315

                 Diluted                         143,315       141,371          142,631



             Entegris, Inc. and Subsidiaries
          Condensed Consolidated Balance Sheets
                      (In thousands)
                       (Unaudited)


                                            April 1,     December 31,
                                              2017             2016
                                           ---------     ------------

    ASSETS

    Cash and cash equivalents                $391,159         $406,389

    Accounts receivable, net                  176,032          165,675

    Inventories                               188,343          183,529

    Deferred tax charges and
     refundable  income taxes                  16,729           20,140

    Other current assets                       19,489           24,398
                                               ------           ------

          Total current assets                791,752          800,131


    Property, plant and equipment, net        330,926          321,562


    Goodwill                                  349,120          345,269

    Intangible assets                         208,591          217,548

    Deferred tax assets                         8,418            8,022

    Other assets                                7,287            7,000

          Total assets                     $1,696,094       $1,699,532
                                           ==========       ==========


    LIABILITIES AND SHAREHOLDERS' EQUITY

    Long-term debt, current maturities       $100,000         $100,000

    Accounts payable                           54,516           61,617

    Accrued liabilities                        66,382           83,530

    Income tax payable                         15,341           16,424
                                               ------           ------

          Total current liabilities           236,239          261,571


    Long-term debt, excluding current
     maturities                               460,315          484,677

    Other liabilities                          54,479           54,066

    Shareholders' equity                      945,061          899,218
                                              -------          -------

          Total liabilities and
           shareholders' equity            $1,696,094       $1,699,532
                                           ==========       ==========



                                                                                       Entegris, Inc. and Subsidiaries
                                                                               Condensed Consolidated Statements of Cash Flows
                                                                                               (In thousands)
                                                                                                 (Unaudited)


                                                                                                                                    Three months ended

                                                                                                                               April 1, 2017   April 2, 2016
                                                                                                                               -------------   -------------

    Operating activities:

    Net  income                                                                                                                      $32,514          $16,212

    Adjustments to reconcile net income to net cash provided by operating activities:

    Depreciation                                                                                                                      13,977           13,700

    Amortization                                                                                                                      10,945           11,289

    Stock-based compensation expense                                                                                                   3,870            2,861

    Provision for deferred income taxes                                                                                                3,422            (211)

    Other                                                                                                                              3,633            4,796

    Changes in operating assets and liabilities:

    Trade accounts and notes receivable                                                                                              (7,546)         (6,799)

    Inventories                                                                                                                      (5,415)        (12,998)

    Accounts payable and accrued liabilities                                                                                        (23,490)         (9,510)

    Income taxes payable and refundable income taxes                                                                                 (1,252)           (726)

    Other                                                                                                                              2,774          (1,275)

    Net cash provided by operating activities                                                                                         33,432           17,339
    -----------------------------------------                                                                                         ------           ------

    Investing activities:

    Acquisition of property and equipment                                                                                           (22,190)        (17,819)

    Other                                                                                                                                186          (2,495)
    -----                                                                                                                                ---           ------

    Net cash used in investing activities                                                                                           (22,004)        (20,314)
    -------------------------------------                                                                                            -------          -------

    Financing activities:

    Payments on long-term debt                                                                                                      (25,000)               -

    Issuance of common stock                                                                                                           1,041                -

    Taxes paid related to net share settlement of equity awards                                                                      (4,575)         (2,067)

    Other                                                                                                                            (4,270)         (3,524)

    Net cash used in financing activities                                                                                           (32,804)         (5,591)

    Effect of exchange rate changes on cash                                                                                            6,146            3,144
    ---------------------------------------                                                                                            -----            -----

    Decrease in cash and cash equivalents                                                                                           (15,230)         (5,422)

    Cash and cash equivalents at beginning of period                                                                                 406,389          349,825
    ------------------------------------------------                                                                                 -------          -------

    Cash and cash equivalents at end of period                                                                                      $391,159         $344,403
    ==========================================                                                                                      ========         ========



                        Entegris, Inc. and Subsidiaries
                              Segment Information
                                 (In thousands)
                                  (Unaudited)


                                                               Three months ended

    Net sales                                         April 1,     April 2,     December 31,
                                                         2017          2016            2016
    ---------                                        ---------     ---------     ------------

    Specialty Chemicals and
     Engineered Materials                              $114,435      $101,107         $110,945

    Microcontamination
     Control                                            100,055        77,619           98,717

    Advanced Materials
     Handling                                           102,887        88,298           98,840
                                                        -------        ------           ------

         Total net sales                               $317,377      $267,024         $308,502
                                                       ========      ========         ========



                                         Three months ended

    Segment profit               April 1,    April 2,    December 31,
                                   2017         2016            2016
    --------------              ---------    ---------    ------------

    Specialty Chemicals and
     Engineered Materials         $28,140      $22,416          $25,919

    Microcontamination Control     35,581       18,140           31,719

    Advanced Materials Handling    18,276       18,911           16,644
                                   ------       ------           ------

    Total segment profit           81,997       59,467           74,282

    Amortization of intangibles    10,945       11,289           10,938

    Unallocated expenses           20,132       18,619           18,439

        Total operating income    $50,920      $29,559          $44,905
                                  =======      =======          =======



                    Entegris, Inc. and Subsidiaries
    Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA
                             (In thousands)
                              (Unaudited)


                                                    Three months ended

                                       April 1, 2017   April 2, 2016    December 31,
                                                                             2016
                                       -------------   -------------   ------------

    Net sales                               $317,377         $267,024         $308,502

    Net income                               $32,514          $16,212          $26,098

    Adjustments to net income:

    Income tax expense                         9,111            4,873            8,521

    Interest expense,
     net                                       8,393            9,149            8,983

    Other expense
     (income), net                               902            (675)           1,303
                                                 ---             ----            -----

    GAAP -Operating
     income                                   50,920           29,559           44,905

    Amortization of
     intangible assets                        10,945           11,289           10,938
                                              ------           ------           ------

    Adjusted operating
     income                                   61,865           40,848           55,843

    Depreciation                              13,977           13,700           14,303
                                              ------           ------           ------

    Adjusted EBITDA                          $75,842          $54,548          $70,146
                                             =======          =======          =======


    Adjusted operating
     margin                                    19.5%           15.3%           18.1%

    Adjusted EBITDA -
     as a % of net
     sales                                     23.9%           20.4%           22.7%
    -----------------                           ----             ----             ----



                    Entegris, Inc. and Subsidiaries
    Reconciliation of GAAP Net Income to Non-GAAP Earnings per Share
                 (In thousands, except per share data)
                              (Unaudited)


                                                    Three months ended

                                       April 1, 2017   April 2, 2016    December 31,
                                                                             2016
                                       -------------   -------------   ------------

    GAAP net income                          $32,514          $16,212          $26,098

    Adjustments to net income:

    Gain on sale of
     equity investment                             -           (118)               -

    Amortization of
     intangible assets                        10,945           11,289           10,938

    Tax effect of
     adjustments to
     net income and
     discrete items                          (2,705)         (3,766)         (2,742)
                                              ------           ------           ------

    Non-GAAP net
     income                                  $40,754          $23,617          $34,294
                                             =======          =======          =======


    Diluted earnings
     per common share                          $0.23            $0.11            $0.18

    Effect of
     adjustments to
     net income                                $0.06            $0.05            $0.06

    Diluted non-GAAP
     earnings per
     common share                              $0.28            $0.17            $0.24
    ----------------                           -----            -----            -----

Contact:
Steven Cantor
VP of Corporate Relations
T + 978 436 6500
irelations@entegris.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/entegris-reports-strong-first-quarter-results-300446862.html

SOURCE Entegris, Inc.